GENEVA – The 79th World Health Assembly (WHA) convened this week under the rallying theme, "Reshaping global health: a shared responsibility," marking a critical juncture in the history of international health policy. As geopolitical tensions, climate change, and the lingering echoes of the COVID-19 pandemic redefine the threat landscape, the World Health Organization (WHO) and its 194 Member States are grappling with the structural reforms necessary to secure a safer, more equitable future.
In his opening address, WHO Director-General Dr. Tedros Adhanom Ghebreyesus set a sober yet determined tone, presenting a comprehensive report on the organization’s activities. The Assembly, which serves as the supreme decision-making body of the WHO, has prioritized the finalization of the Pandemic Agreement—a cornerstone of the global effort to ensure that the systemic failures witnessed during the 2020 crisis are never repeated.
The Pathogen Access and Benefit Sharing (PABS) Impasse
At the heart of the ongoing negotiations is the Pathogen Access and Benefit Sharing (PABS) system, an essential annex to the proposed WHO Pandemic Agreement. While the Assembly has made significant strides in drafting the broader agreement, the complexities surrounding the sharing of pathogen genetic data and the reciprocal sharing of benefits—such as vaccines, therapeutics, and diagnostics—remain a point of intense diplomatic friction.
A Mandate for Continued Negotiation
The World Health Assembly has officially decided to extend the drafting and negotiation phase for the PABS Annex under the Intergovernmental Working Group (IGWG). Mandated by Article 12 of the Pandemic Agreement, the IGWG is tasked with balancing the urgent need for scientific data sharing with the sovereign rights of nations and the necessity of equitable access to medical countermeasures.
The complexity of the PABS mechanism cannot be overstated. It requires a delicate trade-off: developing nations argue that they cannot be expected to share vital pathogen samples if they are subsequently left at the back of the queue for the resulting life-saving products. Conversely, advanced economies and pharmaceutical sectors seek to protect intellectual property and ensure the rapid pace of R&D.
Member States have agreed to reconvene for the seventh meeting of the IGWG, scheduled for July 6–17, 2026. The goal remains to submit a finalized outcome for the Eightieth World Health Assembly in May 2027, or perhaps sooner via a dedicated special session later in 2026. Adoption of this annex is not merely a procedural hurdle; it is the linchpin required to trigger the opening for signature of the landmark WHO Pandemic Agreement.
Crisis Management: Health Emergencies in Committee A
While the high-level debates on treaties dominated the headlines, Committee A turned its focus to the immediate and harrowing realities of health emergencies. The committee reviewed the status of the International Health Regulations (IHR 2005) and scrutinized the latest findings from the Independent Oversight and Advisory Committee for the WHO Health Emergencies Programme.
Conflict and the Erosion of Health Security
A significant portion of the discourse focused on the health impacts of ongoing conflicts in the Middle East. Delegates expressed grave concern over the systematic destruction of health infrastructure and the increasing dangers faced by frontline health workers. The protection of "health neutrality" in conflict zones was a central pillar of the discussion.
In a poignant display of consensus, the Committee adopted a draft decision specifically addressing the health emergency in Lebanon. This move underscores the WHO’s commitment to acting as a neutral arbiter and provider of humanitarian aid, even in the most volatile geopolitical environments. The delegates reiterated that healthcare facilities must never be targets, emphasizing that the degradation of health systems in conflict zones inevitably spills over into regional and global health security threats.
A Decade of Transformation: Reflecting on the WHO Health Emergencies Programme
Coinciding with the 79th WHA, the organization marked the tenth anniversary of the WHO Health Emergencies Programme (WHE). On the margins of the assembly, a strategic roundtable brought together global leaders to dissect the evolution of the organization from the pre-2016 era to the post-COVID-19 reality.
From Reactive to Proactive: The "Ultimate Stress Test"
Dr. Tedros Adhanom Ghebreyesus described the COVID-19 pandemic as the "ultimate stress test" for the international system. He noted that while the pandemic exposed profound vulnerabilities in global trust and equity, it also served as a catalyst for unprecedented innovation and collaborative research.
Dr. Mike Ryan, former Executive Director of the WHE, provided a sobering historical perspective. He argued that for decades, global health systems have been trapped in a "cycle of panic and neglect." Following the SARS outbreak in 2003 and the Ebola crisis in 2014, the world promised reform, yet progress remained reactive. Today, the focus must shift to "epidemic intelligence"—the ability to detect, analyze, and communicate threats before they spiral into global crises.
Expert Insights: The Three Pillars of Future Preparedness
The roundtable identified three critical areas for transformation:
- Epidemic Intelligence and AI: Professor Johanna Hanefeld of the Robert Koch Institute highlighted that advanced analytics and artificial intelligence are no longer optional. However, she warned that these tools are only as effective as the national systems that feed them and the public trust that sustains them.
- Sustainable Financing: Dr. Daniela Garone of Médecins Sans Frontières challenged the current reliance on "emergency-only" funding. She argued that sustainable, flexible financing is the only way to build resilient systems that can pivot instantly when a new pathogen emerges.
- End-to-End Countermeasures: Dr. John-Arne Røttingen of the Wellcome Trust stressed that scientific breakthroughs are meaningless if they are trapped in silos. The goal of the PABS system and the broader Pandemic Agreement must be to create a seamless pipeline where scientific discovery leads directly to global, equitable access.
Country Perspectives: Lessons from the Frontlines
The Assembly showcased real-world examples of how countries are integrating these global lessons into their national architectures.
- Ethiopia: Minister of Health Dr. Mekdes Daba Feyssa shared how the trauma of COVID-19 forced a total overhaul of her nation’s laboratory and oxygen infrastructure. This investment did not just serve a pandemic; it bolstered the country’s capacity to handle subsequent, smaller-scale outbreaks, proving that preparedness is a long-term development investment.
- Central African Republic: Minister Dr. Pierre Somsé emphasized the importance of the Universal Health and Preparedness Review (UHPR). By aligning political commitment with community-level action, the CAR is demonstrating that even resource-constrained nations can build robust surveillance and response networks if the approach is integrated rather than vertical.
Implications: The Road to 2027
The 79th World Health Assembly has reinforced a singular, powerful message: the era of fragmented health security is over. The progress made on the IHR reforms and the ongoing, albeit difficult, negotiations on the PABS Annex indicate that the world is moving toward a more structured, rule-based approach to pandemics.
However, the "shared responsibility" mentioned in the theme is not a guarantee of success. The true test will occur in the coming months as the IGWG resumes its work. If the Member States fail to bridge the divide on benefit-sharing, the entire Pandemic Agreement—and the global commitment to a unified response—risks stagnation.
As delegates depart Geneva, the atmosphere is one of cautious optimism. The consensus is clear: COVID-19 revealed the exorbitant costs of unpreparedness. The question now is whether the international community has the political will to invest in the collective safety of the global population before the next "stress test" arrives. The transition from the lessons of the past decade to the implementation of the next generation of health policy is underway, but the final, most difficult, steps remain ahead.
About the Author
